Improving visual memory with Aricept (donepezil hydrochloride, E2020) in mild-to-moderate Alzheimer's disease

This source preferred by Simon Thompson

Authors: Thompson, S., MacDonald, J. and Coates, T.D.

http://www.haworthpress.com/store/ArticleAbstract.asp?sid=MHARV5QDV1LL9KSURDR013LWK4CV9PQE&ID=9366

Journal: Clinical Gerontologist

Volume: 24

Pages: 55-73

ISSN: 0731-7115

DOI: 10.1300/J018v24n01_05

This data was imported from Scopus:

Authors: Thompson, S.B.N., MacDonald, J. and Coates, T.D.

Journal: Clinical Gerontologist

Volume: 24

Issue: 1-2

Pages: 55-73

ISSN: 0731-7115

DOI: 10.1300/J018v24n01_05

Sixteen patients diagnosed with mild-to-moderate Alzheimer's disease were assessed at two time points, pre- and post-treatment with Aricept, an acetylcholine esterase inhibitor. A battery of standardised neuropsychological tests was administered in addition to recording dose tolerance and maintenance. All patients significantly improved their scores on tests measuring visual memory, visuo-spatial skills, and auditory verbal memory after an interval of approximately 16 weeks. These findings support those of past studies that found an overall increase in cognitive functioning. However, these findings are unique in finding significant improvement in specific measures of visual memory and visuo-spatial functioning. © 2001 by The Haworth Press, Inc. All rights reserved.

The data on this page was last updated at 04:55 on June 17, 2019.